Lai, Jonathan Y. M.
Riley, David R.
Anson, Matthew
Henney, Alex
Cuthbertson, Daniel J.
Hernadez, Gema
Austin, Philip
Lip, Gregory Y. H.
Zhao, Sizheng Steven
Jackson, Timothy L.
Nabrdalik, Katarzyna
Alam, Uazman
Article History
Received: 4 January 2024
Accepted: 31 January 2024
First Online: 24 February 2024
Declarations
:
: Daniel J Cuthbertson has received investigator-initiated grants from Astra Zeneca and Novo Nordisk and support for education from Perspectum; Gema Hernadez and Philip Austin are employees of TriNetX LLC; Gregory Y H Lip is a consultant and speaker for BMS/Pfizer, Boehringer Ingelheim, Daiichi-Sankyo, Anthos. No fees are received personally. He is a National Institute for Health and Care Research (NIHR) Senior Investigator and co-principal investigator of the AFFIRMO project on multimorbidity in AF, which has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No 899871; Timothy L Jackson is a consultant/advisor to 2CTech; Alcon; Dutch Ophthalmic Research Centre; iLumen; Opthea; Outlook Therapeutics; Oxurion; Regeneron. His NHS employer receives site fees for patients enrolled on commercial retinal trials of conditions treated by anti-VEGF therapy. Oraya/Zeiss provided free use of device for NIHR-funded RCT; Bayer provided free provision and distribution of Eylea for Euretina/Fight for Sight funded trial; Uazman Alam has received honoraria from Procter & Gamble, Viatris, Grunenthal, Eli Lilly and Sanofi for educational meetings. UA has also received investigator-led funding by Procter & Gamble; Jonathan Y M Lai, David R Riley, Matthew Anson, Alex Henney, Sizheng Steven Zhao, and Katarzyna Nabrdalik declare no conflicts of interest to declare. Uazman Alam is an Editorial Board member of Diabetes Theray. Uazman Alam was not involved in the selection of peer reviewers for the manuscript nor any of the subsequent editorial decisions.
: All data collection, processing and transmission are performed in compliance with all Data Protection laws applicable to the contributing HCOs, including the EU Data Protection Law Regulation 2016/679, the General Data Protection Regulation on the protection of natural persons regarding the processing of personal data and the Health Insurance Portability and Accountability Act, the US federal law, which protects the privacy and security of healthcare data. Ethics approval was not required. Permission to access and publish data from this study was granted by TriNetX LLC.